Nature Communications (Oct 2022)
Neutralizing and interfering human antibodies define the structural and mechanistic basis for antigenic diversion
Abstract
The Plasmodium falciparum Merozoite Surface Protein 1 (MSP-1) is a prime vaccine candidate for malaria. Here, the authors structurally and functionally characterise a panel of naturally acquired MSP-1 specific antibodies to identify one with potent broadly neutralising activity and better understand immune evasion mechanisms.